Patents by Inventor Mark C. Poznansky

Mark C. Poznansky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOCALIZED DELIVERY OF ANTI-FUGETACTIC AGENT FOR TREATMENT OF CANCER
    Publication number: 20180256742
    Abstract: The invention described herein relates to methods and compositions for treating cancer in a patient, or a tumor cell, by administering an effective amount of an antibody-anti-fugetactic agent complex.
    Type: Application
    Filed: September 16, 2016
    Publication date: September 13, 2018
    Inventor: Mark C. Poznansky
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180193438
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 12, 2017
    Publication date: July 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • METHODS FOR DETECTING AND TREATING CANCER
    Publication number: 20180172691
    Abstract: The invention generally features compositions and methods for the diagnosis, treatment, and monitoring of neoplasia in a subject, as well as methods of treatment selection.
    Type: Application
    Filed: February 5, 2018
    Publication date: June 21, 2018
    Inventors: Mark C. Poznansky, Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre LeBlanc
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180161411
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 13, 2017
    Publication date: June 14, 2018
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • COMPOSITIONS FOR THE TREATMENT OF CANCER
    Publication number: 20180117005
    Abstract: The invention described herein relates to compositions for treating cancer in a patient, or a tumor cell, by administering an effective amount of AMD3100 over a period of time.
    Type: Application
    Filed: April 25, 2016
    Publication date: May 3, 2018
    Inventors: Patrick Reeves, Mark C. Poznansky
  • ANTI-FUGETACTIC AGENT AND IMMUNOTHERAPY AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER
    Publication number: 20180117006
    Abstract: The invention described herein relates to methods and compositions for treating cancer in a patient, or a tumor cell, by administering an effective amount of an anti-fugetactic agent and an immunotherapy agent.
    Type: Application
    Filed: April 25, 2016
    Publication date: May 3, 2018
    Inventors: Mark C. Poznansky, Patrick Reeves
  • ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER
    Publication number: 20180117155
    Abstract: The invention described herein relates to methods and compositions for treating cancer in a patient or a tumor cell by administering an effective amount of an anti-fugetactic agent and an additional anti-cancer agent.
    Type: Application
    Filed: April 25, 2016
    Publication date: May 3, 2018
    Inventors: Mark C. Poznansky, Patrick Reeves
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180099036
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides antifugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • ANTI-FUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180099037
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts Jr., Fabrizio Vianello, Natalia Papeta
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180099034
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts, Fabrizio Vianello, Natalia Papeta
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20180099035
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: December 11, 2017
    Publication date: April 12, 2018
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • ELUTING MATRIX AND USES THEREOF
    Publication number: 20180075706
    Abstract: CXCL12 polypeptide eluting matrices encapsulating at least one cell are described for use in the treatment of autoimmune disorders.
    Type: Application
    Filed: November 15, 2017
    Publication date: March 15, 2018
    Inventors: Mark C. Poznansky, Tao Chen
  • Methods for detecting and treating cancer
    Patent number: 9885720
    Abstract: The invention generally features compositions and methods for the diagnosis, treatment, and monitoring of neoplasia in a subject, as well as methods of treatment selection.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: February 6, 2018
    Assignee: The General Hospital Corporation
    Inventors: Mark C. Poznansky, Hajah Siti Fatimah Jaafar, Dulcie V. Coleman, Pierre LeBlanc
  • Eluting matrix and uses thereof
    Patent number: 9849159
    Abstract: CXCL12 polypeptide eluting matrices encapsulating at least one cell are described for use in the treatment of autoimmune disorders.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: December 26, 2017
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Mark C. Poznansky, Tao Chen
  • ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
    Publication number: 20170319676
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Application
    Filed: July 24, 2017
    Publication date: November 9, 2017
    Inventors: Mark C. Poznansky, John T. Potts, JR., Fabrizio Vianello, Natalia Papeta
  • Anti-fugetactic agents for the treatment of ovarian cancer
    Patent number: 9789171
    Abstract: This invention provides methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention provides anti-fugetactic agents and methods for the use thereof in enhancing an immune response.
    Type: Grant
    Filed: November 4, 2005
    Date of Patent: October 17, 2017
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Mark C. Poznansky, John T. Potts, Jr., Fabrizio Vianello, Natalia Papeta
  • Eluting matrix and uses thereof
    Patent number: 9775816
    Abstract: CXCL12 polypeptide eluting matrices encapsulating at least one cell are described for use in the treatment of autoimmune disorders.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: October 3, 2017
    Assignee: The General Hospital Corporation
    Inventors: Mark C. Poznansky, Tao Chen
  • Antigen-Binding Fusion Proteins with Modified HSP70 Domains
    Publication number: 20170260286
    Abstract: The invention relates to fusion proteins comprising an antigen binding domain fused with a modified heat shock 70 protein. The invention further relates to methods of using the fusion proteins to induce an immune response to antigens and to treat diseases associated with antigens.
    Type: Application
    Filed: March 10, 2017
    Publication date: September 14, 2017
    Inventors: Timothy Brauns, Mark C. Poznansky, Jeffrey A. Gelfand, Huabiao Chen, Stephen J. McCormack
  • ELUTING MATRIX AND USES THEREOF
    Publication number: 20170246250
    Abstract: CXCL12 polypeptide eluting matrices encapsulating at least one cell are described for use in the treatment of autoimmune disorders.
    Type: Application
    Filed: May 9, 2017
    Publication date: August 31, 2017
    Inventors: Mark C. Poznansky, Tao Chen
  • LASER ADJUVANTS FOR ENHANCING IMMUNE RESPONSE
    Publication number: 20170157417
    Abstract: Methods for enhancing an immune response to a vaccine using co-administration of radiation.
    Type: Application
    Filed: July 14, 2016
    Publication date: June 8, 2017
    Inventors: Satoshi Kashiwagi, Mark C. Poznansky